Neuss

• A study to test how either a capsule or a tablet with NDec (Decitabine and Tetrahydrouridine) works in the body of healthy people Not authorised
  2023-504582-22-00 1 Sickle Cell Disease
• Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D Not authorised
  2023-508054-25-00 3 Type 2 diabetes
• A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants with Type 2 Diabetes Mellitus(T2DM … Pending
  2025-521401-41-00 3 Type 2 Diabetes Mellitus (T2DM) and overweight or obesity
• A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity Pending
  2025-523873-41-00 3 Overweight Obesity
• A three-part first-in-human trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of GUB-UCN2 in healthy lean and obes … Pending
  2025-524921-42-00 1 Type 2 Diabetes
• A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab a … Recruiting
  2023-505172-29-00 4 2025-04-24 Resectable Non-small Cell Lung Cancer
• A study to test whether survodutide helps people living with obesity or overweight and with a confirmed or presumed liver disease called non … Recruiting
  2023-505303-23-00 5 2024-07-26 Obesity
• Bioavailability, Biopotency and Food effect study of SCD0503 compared to subcutaneous regular human insulin Recruiting
  2024-519502-12-00 1 2026-05-29 Type 1 diabetes
• A research study investigating the effect of NNC0497-0040 in healthy participants, participants with overweight or obesity, and participants … Recruiting
  2025-523978-16-00 1 2026-05-04 Type I diabetes
• Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes Recruiting
  2025-521595-55-00 3 2026-03-25 Type 2 Diabetes
• Safety and efficacy of BNT327, an investigational therapy, in combination with chemotherapy for patients with untreated small-cell lung canc … Recruiting
  2024-515765-34-00 5 2026-02-04 English First-line extensive-stage small-cell lung cancer (ES-SCLC)
• A phase 1 glucose clamp trial investigating the bioequivalence of CVC-001 cartridge vs U.S.-Licensed Lantus® in healthy male volunteers Recruiting
  2024-516472-15-00 2 2026-01-06 Type 1 diabetes mellitus (healthy participants)
• A research study of a new medicine, NNC9733-0001, in healthy participants and participants with type 2 diabetes Recruiting
  2024-519382-22-00 1 2025-11-10 Healthy Participants and Participants with type 2 diabetes
• A Trial to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR4 Compared with Insulin Degludec and Insulin … Recruiting
  2025-522662-67-00 3 2025-08-13 Type 2 Diabetes Mellitus
• Safety, efficacy, and pharmacokinetics of BNT327 in combination with chemotherapy and other investigational agents for lung cancer Recruiting
  2024-515764-31-00 10 2025-06-13 Non-small cell lung cancer
• A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellit … Recruiting
  2024-518470-13-00 3 2025-05-30 Diabetes Mellitus
• A Study of LY4057996 in Healthy Participants and Participants with Type 1 and Type 2 Diabetes (YKAA) Recruiting
  2024-519151-28-00 1 2025-05-14 Healthy, Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2
• A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389 Recruiting
  2024-514853-31-00 1 2024-09-10 Obesity / Right heart failure (healthy participants)
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3938577 in Healthy Participants and Participants wit … Recruiting
  2023-510365-10-00 3 2024-04-29 Type 1 Diabetes Mellitus
• A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting
  2022-502113-28-00 5 2024-02-01 Follicular lymphoma
• A trial to learn if odronextamab combined with lenalidomide is safe and works better than rituximab combined with lenalidomide in adult part … Recruiting
  2022-503092-28-00 5 2024-01-08 Relapsed/Refractory Follicular Lymphoma
• A study to assess efficacy and safety of benralizumab in paediatric patients with severe eosinophilic asthma (severe asthma marked by high … Recruiting
  2022-501344-14-00 5 2023-06-05 Paediatric Patients with Severe Eosinophilic Asthma Asthma is a long-t
• A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults wi … Recruiting
  2022-501187-18-00 5 2023-04-24 a. Diffuse large B-cell lymphoma (DLBCL) not otherwise specified (NOS)
• Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized, … Recruiting
  2024-512174-10-00 5 2021-11-11 metastatic colorectal cancer

Showing 1–24 of 54 trials